Hims & Hers is spiking on Monday amid some remarks that Health and Human Services Secretary Robert F Kennedy Jr made on the Joe Rogan Experience podcast.

At around the 1.5 hour mark of the podcast, RFK Jr indicates that he’s “very anxious” to make about 14 peptides more accessible (and allow for compounding), and that the FDA is currently “looking at the science” of these treatments.

“My hope is that they’re going to get moved to a place where people have access from ethical suppliers,” he said.

A more permissive stance towards these peptides — short chains of amino acids that regulate a variety of processes in the body and are the active ingredient in popular GLP-1 medications used to treat diabetes and weight loss — would potentially open up substantial new revenue opportunities for Hims.

As for why the stock didn’t react more on Friday, well, that’s a bit of a noodle-scratcher. But this episode was released at 1 p.m. ET, and may not have had enough time to be fully digested and disseminated before the weekend.

The legal and regulatory apparatuses have been a big headwind for Hims in 2026, but perhaps these remarks (and the reaction) are a signal that these winds might be starting to shift.

Investors appear to be rotating where they are placing their crypto bets, but not necessarily fleeing the asset class entirely. 

Last month, spot bitcoin ETFs registered $206.5 million in outflows, marking their fourth straight month of redemptions. Ethereum spot ETFs saw even heavier withdrawal as $369.9 million left the investment vehicles, also marking a fourth consecutive monthly outflow. 

Since November, spot bitcoin and ethereum ETFs have posted more than $9.1 billion in cumulative outflows.

Bitcoin and ethereum are the market’s virtual ATMs, according to Chris Soriano, cofounder and chief commercial officer at BridgePort. “It’s no surprise when institutions start laying off risk or meet redemptions, they naturally sell what’s most liquid first,” Soriano told Sherwood News. “This is no different than when a traditional fund manager trims S&P 500 exposure before touching their small-cap growth positions.” 

On the other hand, newer funds based on altcoins haven’t stopped recording monthly green candles. 

Spot XRP ETFs pulled in $58 million last month and have yet to post a single negative month since their launch in November. Spot solana ETFs attracted $63 million and, likewise, remain in the black since their debut in October. 

The outflows of the two largest cryptocurrencies combined with the modest inflows of the two smaller tokens suggest a rotation regime, Soriano argued. “Institutions trimming their core liquid holdings while selectively adding to high-conviction, higher-beta positions where they think there’s more juice in the squeeze. It’s not a contradiction; it’s portfolio mechanics behaving exactly as you’d expect,” Soriano continued.

He added that XRP and solana’s markets are also thinner, which means the same dollar of buying pressure registers as a louder, more persistent inflow signal than it ever would in BTC or ETH.

Nic Roberts-Huntley, CEO and cofounder of Blueprint Finance, told Sherwood that bitcoin and etheruem’s outflows combined with XRP and solana’s inflows “may signal a broader market transition, one where capital increasingly chases specific use cases rather than the entire asset class moving in lockstep.”

Traders seem to be settling on satellite stocks as a smart place to stash cash after the combined US and Israeli attack on Iran ignited a fresh war in the Middle East over the weekend.

Planet Labs, AST SpaceMobile, and Firefly Aerospace are all posting strong gains, as are related space plays like Intuitive Machines and traditional defense contractors like Northrop Grumman, which has a growing space services division.

Scenes of the aftermath of missile and drone strikes underscore the importance of imaging and communications technology offered by the low-Earth orbital satellite services some of these companies offer. Sadly, the scale of the destruction in the region suggests such services will be in heavy demand from governments worldwide for the foreseeable future.

The Screen Actors Guild hosted its Actor Awards on Sunday, with the film awards closely monitored ahead of the Academy Awards. The Best Supporting Actor and Actress races remain suspenseful as Sean Penn (“One Battle After Another”) and Amy Madigan (“Weapons”) took home the Actor Awards in those respective categories, shifting the odds in both markets predicting who’ll take home the Oscar.

(Event contracts are offered through Robinhood Derivatives, LLC — probabilities referenced or sourced from KalshiEx LLC or ForecastEx LLC.)

But the most exciting race is for Best Actor. Several award pundits and experts predicted that “Marty Supreme” star Timothée Chalamet was a lock for the Actor Award despite his loss at the BAFTA Film Awards the previous weekend. But a few suggested that either “Blue Moon” lead Ethan Hawke or Michael B. Jordan could receive the honor instead. And that’s exactly what happened when the “Sinners” star was announced as the winner.

While some have pointed out that the Actor Awards aren’t a reliable signifier for who will win the Oscar (Demi Moore and Chalamet received the SAG honors last year, but didn’t win the Oscar), it certainly puts Jordan at a higher advantage and makes the Best Actor race closer than it’s ever been. Chalamet previously had a higher lead in the prediction markets, but markets are now pricing in a 49% chance he takes the Oscar while Jordan’s odds have risen to 40%.

Palantir jumped in early trading Monday, with shares on track for their best day in weeks after the outbreak of war in the Middle East reinvigorated investor interest in a company that is an intelligence and defense contractor to the US and Israel.

Despite impressive recent business results driven by its corporate AI software division, Palantir has lost some of the previously rapt attention of individual investors, a group of shareholders who were a cornerstone of the stock’s more than 400% rise over the last two years.

In a note published last week, JPMorgan analyst Arun Jain, who keeps a close eye on trends among individual traders, noted that retail “paused PLTR purchases last September.”

The stock topped out not long after that, hitting a record of $207.52 in early November. Even after Monday’s bounce, the shares are down about 30%, having tumbled through key technical levels that confirm the downshift in momentum.

But with the attention of the markets now clearly on the war in Iran and the wider region, Palantir’s attributes as a defense and intelligence contractor for the US government — it took in $1.9 billion from US government customers last year, 42% of total revenue — as well as Israel seem to be getting the company a second look.

Shares of Nvidia are on the rise in early trading Monday after Morgan Stanley called the world’s most valuable company its most attractive opportunity among semiconductor stocks and after management reached a pair of deals with optical communications companies.

Morgan Stanley analyst Joseph Moore writes that concerns about a peak in AI-driven demand should give way to optimism about Nvidia’s 2027 sales prospects.

“In each of the last three years, early in the year there was skepticism about the following year, and each time when visibility filled in and we realized the strength was durable, the stock had bursts of outperformance,” the analyst wrote.

He expects that Nvidia’s upcoming GPU Technology Conference, which the company is hosting from March 16 through 19, will enhance investors’ confidence about its ability to retain a dominant market position.

The analyst returned Nvidia to Morgan Stanley’s top slot, replacing Micron, which had taken the pole position in November from Sandisk, which had supplanted Nvidia back in September.

Per Moore:

“Memory vs. NVIDIA is an interesting debate. There is a commonly voiced view that memory stocks are pricing in a much longer and more durable cycle than processor stocks; we actually somewhat disagree with that. Our memory conversations with clients are very similar to NVIDIA conversations — a clear recognition that conditions are exceptional in both right now, But a very strong peak year at current valuations has been viewed as more investable for memory, because upward revisions are more dynamic. There is not much conviction about 2027 for either stock.”

As we discussed ahead of Nvidia’s earnings, memory has been the AI shortage that commanded more investor attention because that cohort was both cheaper and seeing more dramatic boosts to sales and earnings estimates than the $4 trillion chip designer.

Separately, Nvidia this morning announced a pair of $2 billion investments into Lumentum and Coherent, which includes purchase commitments for their optical technologies.

Video game console makers Nintendo and Sony are down in premarket trading Monday, amid a broad sell-off following US strikes against Iran over the weekend.

Both companies rely on cargo ships to transport consoles from factories in Asia to global consumers. An increase in shipping costs could add to the headache console makers are already facing from tariffs and sharply elevated memory prices.

Per Bloomberg, current rerouting plans to avoid the Suez Canal could add more than 10 days to deliveries.

Other factors are also dampening the stocks. Sony is facing a $2.7 billion UK lawsuit — with a trial set to begin next week — alleging that the PlayStation Store “has a near monopoly” on digital games and add-ons. Nintendo last week announced a roughly $1.9 billion share sale by major investors.